insights_auto
Why is ORX down 23.39%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEKÂ 1.05
arrow_downward
-23.39%(-0.32) 1D
Nov 9, 5:29:41 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEKÂ 1.03
High
SEKÂ 1.25
Low
SEKÂ 0.99
Mkt. cap
36.76M
Avg. vol.
337.59K
Volume
1.28M
P/E ratio
0.05
52-wk high
SEKÂ 36.00
52-wk low
SEKÂ 0.99
EPS
SEKÂ 21.73
Shares outstanding
35.13M
No. of employees
55
Open
SEKÂ 1.03
High
SEKÂ 1.25
Low
SEKÂ 0.99
Mkt. cap
36.76M
Avg. vol.
337.59K
Volume
1.28M
P/E ratio
0.05
52-wk high
SEKÂ 36.00
52-wk low
SEKÂ 0.99
EPS
SEKÂ 21.73
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
Bloomberg.com
·
4 hours ago
Watch S&P 500 Erases Midterm Losses, Bitcoin Bounce
Investing.com
·
4 hours ago
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.15%
24/7 Wall St.
·
7 hours ago
Verizon’s Dividends Kept $1,000 Afloat at $1,580 While the S&P 500 Reached $3,910
StoneX
·
10 hours ago
S&P 500 Forecast: SPX rises despite Nvidia’s decline
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com